ORBIMED ADVISORS LLC Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$8.4B
Holdings
142
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (142 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RCKTROCKET PHARMACEUTICALS INC | 775,000 | $15.2B | 181.44% | |
| 102 | AMEDAMEDISYS INC | 171,100 | $14.6B | 174.40% | |
| 103 | BMRNBIOMARIN PHARMACEUTICAL INC | 146,500 | $13.8B | 164.59% | Call |
| 104 | —NABRIVA THERAPEUTICS PLC | 3,919,600 | $13.6B | 162.68% | |
| 105 | NBIXNEUROCRINE BIOSCIENCES INC | 137,800 | $13.5B | 161.45% | |
| 106 | THCTENET HEALTHCARE CORP | 372,900 | $12.5B | 149.30% | |
| 107 | —TRIPLE-S MGMT CORP | 290,800 | $11.4B | 135.48% | |
| 108 | —WRIGHT MED GROUP N V | 8,746,583 | $11.2B | 133.53% | |
| 109 | NVTA1EURINVITAE CORP | 1,518,197 | $11.2B | 133.09% | |
| 110 | —AEGERION PHARMACEUTICALS INC | 15,000,000 | $9.7B | 115.91% | |
| 111 | PRQRPROQR THRAPEUTICS N V | 1,302,955 | $9.5B | 113.45% | |
| 112 | —DERMIRA INC | 1,031,596 | $9.5B | 113.20% | |
| 113 | FLBFLUIDIGM CORP DEL | 1,583,700 | $9.4B | 112.58% | |
| 114 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $8.1B | 96.52% | |
| 115 | ATNXEURATHENEX INC | 430,000 | $8.0B | 95.70% | |
| 116 | —DBV TECHNOLOGIES S A | 410,700 | $7.9B | 94.48% | |
| 117 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 666,593 | $7.9B | 94.37% | |
| 118 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $7.2B | 86.04% | |
| 119 | —AVROBIO INC | 250,000 | $7.1B | 85.16% | |
| 120 | —ARSANIS INC | 1,868,966 | $6.8B | 80.91% | |
| 121 | ECORGBPELECTROCORE INC | 397,826 | $6.6B | 78.34% | |
| 122 | ALKSALKERMES PLC | 145,000 | $6.0B | 71.18% | |
| 123 | XENEXENON PHARMACEUTICALS INC | 634,812 | $5.8B | 69.65% | |
| 124 | RAREULTRAGENYX PHARMACEUTICAL IN | 67,605 | $5.2B | 61.98% | |
| 125 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $4.8B | 57.48% | |
| 126 | —MARINUS PHARMACEUTICALS INC | 567,600 | $4.0B | 47.86% | |
| 127 | STIMNEURONETICS INC | 150,000 | $4.0B | 47.61% | |
| 128 | —SIERRA ONCOLOGY INC | 1,267,104 | $3.8B | 44.74% | |
| 129 | KIDSORTHOPEDIATRICS CORP | 136,900 | $3.6B | 43.50% | |
| 130 | —AKORN INC | 200,000 | $3.3B | 39.57% | Call |
| 131 | SNDXSYNDAX PHARMACEUTICALS INC | 437,000 | $3.1B | 36.59% | |
| 132 | —TESARO INC | 67,281 | $3.0B | 35.69% | |
| 133 | —GW PHARMACEUTICALS PLC | 21,000 | $2.9B | 34.95% | |
| 134 | —ADAMAS PHARMACEUTICALS INC | 100,000 | $2.6B | 30.81% | Call |
| 135 | AUPHAURINIA PHARMACEUTICALS INC | 167,419 | $943.0M | 11.25% | |
| 136 | —BIOLINERX LTD | 1,038,600 | $924.0M | 11.02% | |
| 137 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $592.0M | 7.06% | |
| 138 | SCTLRECRO PHARMA INC | 107,357 | $539.0M | 6.43% | |
| 139 | —AFFIMED N V | 326,650 | $539.0M | 6.43% | |
| 140 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $532.0M | 6.35% | |
| 141 | —ALIMERA SCIENCES INC | 250,000 | $245.0M | 2.92% | |
| 142 | —MEDIGUS LTD | 60,000 | $74.0M | 0.88% |
PreviousPage 2 of 2